Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Breakthrough trial for motor neuron disease

Written by | 22 Mar 2021

Researchers at Trinity College Dublin are to participate in an early phase gene-based clinical trial for motor neuron disease (MND). The research team represents one of only four… read more.

Allarity Therapeutics initiates phase II trial of Ixempra in Europe for the treatment of metastatic breast cancer

Written by | 21 Mar 2021

Allarity Therapeutics A/S announced that it has enrolled the first patient in its European Phase II clinical trial of Ixempra (ixabepilone) for the treatment of metastatic breast cancer.

Type 2 diabetes is associated with increased risk of Parkinson’s

Written by | 21 Mar 2021

Research from Queen Mary University of London has concluded that there is convincing evidence that type 2 diabetes is associated with an increased risk of Parkinson’s disease. The… read more.

Lupin will partner with Endoceutics to commercialise Intrarosa for postmenopausal vulvovaginal atrophy in Canada

Written by | 20 Mar 2021

Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, announced a partnership with Endoceutics, a women’s health focused innovative Canadian biotech company, to commercialize Intrarosa in Canada.

Two servings of fish per week can help prevent recurrent heart disease

Written by | 20 Mar 2021

An analysis of several large studies involving participants from more than 60 countries, spearheaded by researchers from McMaster University, has found that eating oily fish regularly can help… read more.

FDA approves Kimyrsa to treat acute bacterial skin and skin structure infections (ABSSSI) – Melinta Therapeutics

Written by | 19 Mar 2021

Melinta Therapeutics, LLC announced that the FDA has approved Kimyrsa (oritavancin) for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by… read more.

New discovery explains antihypertensive properties of green and black tea

Written by | 19 Mar 2021

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the… read more.

CD14+ monocytes and RA – implications for practice and research

Written by | 19 Mar 2021

Interview and article by Christine Clark. Dr Megan Hanlon and Professor Ursula Fearon describe the implications of their research findings for future practice and research in rheumatoid arthritis…. read more.

Interim SAGE/WHO recommendation supporting the use of the Johnson & Johnson COVID-19 Vaccine

Written by | 18 Mar 2021

Johnson & Johnson welcomes the interim recommendation by the Strategic Advisory Group of Experts (SAGE) on Immunization for the World Health Organization (WHO) supporting the use of Johnson… read more.

EU grants conditional approval for single-dose COVID-19 vaccine JNJ 78436735 – Johnson & Johnson

Written by | 18 Mar 2021

Johnson & Johnson announced that the European Commission (EC) has granted a Conditional Marketing Authorization (CMA) for its single-dose COVID-19 vaccine JNJ 78436735, developed by the Janssen Pharmaceutical… read more.

Semaglutide cuts body weight in at-risk obese patients

Written by | 18 Mar 2021

Article by Bruce Sylvesyter. In tandem with lifestyle management, once-weekly semaglutide therapy has enabled obese, non-diabetic patients to lose a significant amount of weight, researchers reported on Feb…. read more.

Investigating the inflammatory changes of RA at molecular level

Written by | 18 Mar 2021

Interview and article by Christine Clark. Professor Ursula Fearon and Dr Megan Hanlon describe a study that investigated the metabolic behaviour of circulating monocytes and how this relates… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.